Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Quanyi Health is a leading integrated pharmaceutical retail and healthcare services provider in China, recognized for its aggressive acquisition-led growth strategy. Founded in 2016 and headquartered in Suzhou, the company operates a massive network of thousands of retail pharmacies across provinces such as Jiangsu, Zhejiang, and Sichuan. The company differentiates itself through a 'Direct-to-Patient' (DTP) pharmacy model and a strong focus on chronic disease management, leveraging digital platforms to enhance patient engagement and treatment adherence. In 2021, Quanyi Health was acquired by the global private equity firm PAG in a landmark transaction aimed at consolidating its market share and advancing its digital healthcare capabilities. The firm serves as a critical commercialization partner for pharmaceutical companies, facilitating the distribution of both traditional medicines and specialty biopharmaceuticals in the Chinese market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Quanyi Health.